| Literature DB >> 34765522 |
Tanuj Dada1, Brajesh Lahri1, Karthikeyan Mahalingam1, Jyoti Shakrawal1, Atul Kumar1, Ramanjit Sihota1, Raj Kumar Yadav2.
Abstract
BACKGROUND AND AIM: Glaucoma is one of the leading causes of visual impairment worldwide. Next to intraocular pressure (IOP), vascular factors play a major role in glaucoma. Mindfulness-based stress reduction (MBSR) has been shown to reduce the IOP, normalize the stress biomarkers, modulate gene expression, and also improve the quality of life. This study was aimed to assess the effect of MBSR in optic disc perfusion of patients with primary open angle glaucoma (POAG). EXPERIMENTAL PROCEDURE: POAG patients with controlled IOP (<21 mmHg) were randomised in to intervention group (n = 30) and control group (n = 30). Both the groups continued their routine glaucoma medications while the intervention group practiced 45 min of MBSR every day in addition. IOP and optic disc perfusion using OCT-Angiography were recorded at baseline and at 6 weeks for both the groups.Entities:
Keywords: Glaucoma; Meditation; OCTA; Optic disc perfusion; Stress reduction
Year: 2021 PMID: 34765522 PMCID: PMC8572716 DOI: 10.1016/j.jtcme.2021.06.006
Source DB: PubMed Journal: J Tradit Complement Med ISSN: 2225-4110
Baseline and Post MBSR comparison of optic disc perfusion in both groups.
| Parameters | Group-1 (MBSR-intervention) | Group-2 (Controls) | G1 vs G2 | G1 vs G2 | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | At 6 Weeks | P Value | Baseline | At 6 Weeks | P Value | |||
| Circumpapillary Vessel Density (in %) | ||||||||
| Superior | 15.83 ± 2.3 | 17.42 ± 2.91 | 15.22 ± 2.61 | 16.52 ± 2.83 | 0.10 | 0.45 | ||
| Temporal | 12.47 ± 1.2 | 13.92 ± 2.82 | 0.43 | 13.73 ± 1.80 | 13.90 ± 1.03 | 0.62 | 0.38 | 0.79 |
| Inferior | 13.02 ± 2.49 | 13.40 ± 2.088 | 0.59 | 14.09 ± 2.77 | 14.53 ± 2.75 | 0.61 | 0.54 | 0.36 |
| Nasal | 14.28 ± 2.47 | 16.52 ± 2.62 | 15.00 ± 2.56 | 16.97 ± 2.53 | 0.53 | 0.48 | ||
| Average Vessel Density | 13.07 ± 2.41 | 14.57 ± 2.35 | 0.14 | 14.65 ± 1.99 | 14.55 ± 2.03 | 0.07 | 0.22 | 0.81 |
| Circumpapillary Vessel Perfusion (in %) | ||||||||
| Superior | 38.96 ± 3.22 | 41.15 ± 3.14 | 40.29 ± 3.24 | 40.17 ± 3.21 | 0.59 | 0.98 | ||
| Temporal | 42.21 ± 4.45 | 44.53 ± 1.89 | 44.95 ± 2.58 | 44.81 ± 2.56 | 0.56 | 0.49 | ||
| Inferior | 40.15 ± 2.86 | 43.85 ± 2.61 | 41.55 ± 3.71 | 41.33 ± 3.68 | 0.69 | 0.41 | ||
| Nasal | 40.60 ± 3.31 | 42.88 ± 2.31 | 41.61 ± 2.36 | 41.52 ± 2.41 | 0.34 | 0.40 | ||
| Flux Index | 0.384 ± 0.04 | 0.40 ± 0.04 | 0.38 ± 0.43 | 0.37 ± 0.43 | 0.74 | 0.53 | ||
Paired t-test, # Independent t-test.
Fig. 1a OCT-Angiography of the right eye of a patient before MBSR showing circumpapillary vascular perfusion and flux index and (1b) after MBSR showing increase in circumpapillary vascular perfusion and flux index.
Baseline and Post MBSR comparison of Heart Rate and Blood Pressure in both groups.
| Parameters | Group-1 (MBSR-intervention) | Group-2 (Controls) | G1 vs G2 | G1 vs G2 6 Weeks | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | At 6 Weeks | P Value | Baseline | At 6 Weeks | P Value | |||
| Intraocular pressure (in mmHg) | 18.06 ± 1.38 | 16.34 ± 1.32 | 18.46 ± 1.46 | 17.65 ± 1.12 | 0.16 | 0.13 | ||
| Heart Rate (In bpm) | 78.23 ± 8.45 | 74.43 ± 7.44 | 77.93 ± 9.61 | 77.91 ± 9.29 | 0.98 | 0.35 | ||
| Systolic Blood Pressure (In mmHg) | 136.63 ± 8.42 | 132.17 ± 9.40 | 134.37 ± 7.37 | 135.37 ± 8.51 | 0.06 | 0.12 | ||
| Diastolic Blood Pressure (In mmHg) | 78.17 ± 4.95 | 74.40 ± 4.95 | 80.93 ± 5.76 | 81.77 ± 6.24 | 0.06 | 0.09 | ||
Paired t-test, # Independent t-test.